BG
CALA

BlackRock Group’s Calithera Biosciences, Inc CALA Stock Holding History

BlackRock Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-631
Closed -$97K – 3074
2015
Q4 		$97K Hold
631
– – ﹤0.01% 2692
2015
Q3 		$69K Hold
631
– – ﹤0.01% 2792
2015
Q2 		$90K Buy
+631
New +$146K ﹤0.01% 2776

Other funds holding CALA

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MMPI
Morgenthaler Management Partners IX Portola Valley, California $22.6M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock Group's CALA Position: Q1 2016 in Review

BlackRock Group sold out of Calithera Biosciences, Inc (CALA) in Q1 2016, closing a stake of 631 shares — an estimated $97K sold.

BlackRock Group first reported a position in CALA in Q2 2015 and held it in 3 quarters. The position peaked at $97K in Q4 2015. 52 funds tracked by Wall St. Rank hold CALA as of Q1 2016.

  • BlackRock Group reported no remaining Calithera Biosciences, Inc position as of Q1 2016 after selling out during the quarter.
  • BlackRock Group sold 631 Calithera Biosciences, Inc shares in Q1 2016, an estimated $97K.
  • BlackRock Group first reported a position in Calithera Biosciences, Inc in Q2 2015 and held it in 3 quarters.
  • BlackRock Group's Calithera Biosciences, Inc position peaked at $97K in Q4 2015.
  • 52 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2016.

Based on BlackRock Group's 13F filing for Q1 2016, filed 10 May 2016.